scPharmaceuticals (SCPH) Competitors

scPharmaceuticals (NASDAQ:SCPH) and GH Research (NASDAQ:GHRS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

Do analysts rate SCPH or GHRS?

scPharmaceuticals presently has a consensus price target of $14.00, suggesting a potential upside of 464.52%. GH Research has a consensus price target of $30.86, suggesting a potential upside of 191.24%. Given scPharmaceuticals' higher probable upside, equities research analysts plainly believe scPharmaceuticals is more favorable than GH Research.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
scPharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
GH Research	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is SCPH or GHRS more profitable?

GH Research has a net margin of 0.00% compared to scPharmaceuticals' net margin of -264.60%. GH Research's return on equity of -20.29% beat scPharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
scPharmaceuticals	-264.60%	-244.93%	-68.56%
GH Research	N/A	-20.29%	-19.49%

Does the media refer more to SCPH or GHRS?

In the previous week, GH Research had 1 more articles in the media than scPharmaceuticals. MarketBeat recorded 6 mentions for GH Research and 5 mentions for scPharmaceuticals. scPharmaceuticals' average media sentiment score of 1.06 beat GH Research's score of 0.95 indicating that scPharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
scPharmaceuticals	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GH Research	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer SCPH or GHRS?

scPharmaceuticals received 133 more outperform votes than GH Research when rated by MarketBeat users. However, 76.92% of users gave GH Research an outperform vote while only 67.08% of users gave scPharmaceuticals an outperform vote.

Company	Underperform	Outperform
scPharmaceuticals	Outperform Votes 163 67.08%	Underperform Votes 80 32.92%
GH Research	Outperform Votes 30 76.92%	Underperform Votes 9 23.08%

Do insiders & institutionals hold more shares of SCPH or GHRS?

89.5% of scPharmaceuticals shares are held by institutional investors. Comparatively, 56.9% of GH Research shares are held by institutional investors. 5.5% of scPharmaceuticals shares are held by company insiders. Comparatively, 41.6% of GH Research shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has preferable earnings and valuation, SCPH or GHRS?

GH Research has lower revenue, but higher earnings than scPharmaceuticals. GH Research is trading at a lower price-to-earnings ratio than scPharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
scPharmaceuticals	$36.33M	3.43	-$54.81M	-$1.90	-1.31
GH Research	N/A	N/A	-$35.59M	-$0.75	-14.13

Which has more volatility & risk, SCPH or GHRS?

scPharmaceuticals has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500. Comparatively, GH Research has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500.

Summary

GH Research beats scPharmaceuticals on 10 of the 16 factors compared between the two stocks.